---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-074293"
form_type: "8-K"
ticker: "RAPH"
cik: "0001415397"
company_name: "Raphael Pharmaceutical Inc."
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:19:20.967605+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Raphael Pharma board member resigns; Zvi Laufer Laor appointed as director

## Summary
- Dr. Igal Louria Hayon resigned from Board effective Aug 1, 2025; no disagreement; remains CTO.
- On Aug 7, 2025, Board appointed Zvi Laufer Laor (age 73, lawyer) to fill vacancy.
- Board determined Mr. Laufer qualified and independent under relevant securities laws.

## SEC filing metadata
- accession: 0001213900-25-074293
- form_type: 8-K
- ticker: RAPH
- cik: 0001415397
- company_name: Raphael Pharmaceutical Inc.
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1415397/000121390025074293/0001213900-25-074293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1415397/000121390025074293/ea0252565-8k_raphael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-074293
- JSON: https://secwatch.observer/filing/0001213900-25-074293.json
- Plain text: https://secwatch.observer/filing/0001213900-25-074293.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.